Stakeholder-informed prioritisation of HealthTech innovation across chronic respiratory disease: the HERON study

IF 9.1 1区医学 Q1 RESPIRATORY SYSTEM

Thorax Pub Date : 2026-09-30 DOI:10.1136/thorax-2026-225806

Zhanna Oganesova,Sofya Panchenko,Nia W Roberts,Lindsay Welch,Fiona Mosgrove,Clare Cook,Gillian Richards,Joanne Salmon,Philip J Turner,Gail N Hayward,Marta Wanat,Helen F Ashdown

{"title":"Stakeholder-informed prioritisation of HealthTech innovation across chronic respiratory disease: the HERON study","authors":"Zhanna Oganesova,Sofya Panchenko,Nia W Roberts,Lindsay Welch,Fiona Mosgrove,Clare Cook,Gillian Richards,Joanne Salmon,Philip J Turner,Gail N Hayward,Marta Wanat,Helen F Ashdown","doi":"10.1136/thorax-2026-225806","DOIUrl":null,"url":null,"abstract":"Background Chronic respiratory disease (CRD) is characterised by high symptom burden and frequent emergency admissions, disproportionately affecting disadvantaged populations. Advances in health technology (HealthTech) offer opportunities to improve health outcomes but are most effective when they target the most pressing needs across the CRD pathway. We aimed to develop and apply a stakeholder-informed prioritisation methodology for HealthTech across adult and paediatric CRD. Methods We used a stakeholder-informed prioritisation methodology designed specifically for HealthTech. National surveys and targeted discussions with people living with CRD, individuals at risk, carers and healthcare professionals identified unmet needs and potential HealthTech solutions. Inductive qualitative content analysis generated a longlist of candidate solution areas, which were mapped against a respiratory technology landscape review to produce evidence summaries of current technological capability. These informed a multistakeholder consensus workshop to identify the top 20 priority HealthTech solution areas for CRD. Results A total of 314 patients, carers and healthcare professionals contributed through surveys and targeted discussions. Stakeholders identified 741 challenges and 555 potential HealthTech solutions, which were synthesised into 73 candidate solution areas across 16 priority domains. The technology landscape review found that 52/73 (71.2%) solution areas remained unmet and 21/73 (28.8%) were partially met by existing HealthTech; none were considered fully met. A multistakeholder consensus workshop identified the top 20 priority HealthTech solution areas for CRD. Conclusion This stakeholder-informed HealthTech prioritisation integrates unmet need with current technological capability to inform policy and funding decisions in CRD. The methodology for HealthTech prioritisation can be applied beyond respiratory care.","PeriodicalId":23284,"journal":{"name":"Thorax","volume":"402 1","pages":"thorax-2026-225806"},"PeriodicalIF":9.1000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thorax","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/thorax-2026-225806","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

Abstract

Background Chronic respiratory disease (CRD) is characterised by high symptom burden and frequent emergency admissions, disproportionately affecting disadvantaged populations. Advances in health technology (HealthTech) offer opportunities to improve health outcomes but are most effective when they target the most pressing needs across the CRD pathway. We aimed to develop and apply a stakeholder-informed prioritisation methodology for HealthTech across adult and paediatric CRD. Methods We used a stakeholder-informed prioritisation methodology designed specifically for HealthTech. National surveys and targeted discussions with people living with CRD, individuals at risk, carers and healthcare professionals identified unmet needs and potential HealthTech solutions. Inductive qualitative content analysis generated a longlist of candidate solution areas, which were mapped against a respiratory technology landscape review to produce evidence summaries of current technological capability. These informed a multistakeholder consensus workshop to identify the top 20 priority HealthTech solution areas for CRD. Results A total of 314 patients, carers and healthcare professionals contributed through surveys and targeted discussions. Stakeholders identified 741 challenges and 555 potential HealthTech solutions, which were synthesised into 73 candidate solution areas across 16 priority domains. The technology landscape review found that 52/73 (71.2%) solution areas remained unmet and 21/73 (28.8%) were partially met by existing HealthTech; none were considered fully met. A multistakeholder consensus workshop identified the top 20 priority HealthTech solution areas for CRD. Conclusion This stakeholder-informed HealthTech prioritisation integrates unmet need with current technological capability to inform policy and funding decisions in CRD. The methodology for HealthTech prioritisation can be applied beyond respiratory care.

查看原文本刊更多论文

慢性呼吸系统疾病的健康技术创新优先事项：HERON研究

慢性呼吸道疾病（CRD）的特点是症状负担高，经常急诊，对弱势群体的影响尤为严重。卫生技术（HealthTech）的进步为改善健康结果提供了机会，但当它们针对整个疾病与发展途径中最紧迫的需求时，效果最为显著。我们的目标是开发和应用一种利益相关者知情的健康技术优先排序方法，适用于成人和儿科CRD。方法我们使用了专门为HealthTech设计的利益相关者知情优先排序方法。全国性调查以及与CRD患者、风险个体、护理人员和医疗保健专业人员进行的有针对性的讨论确定了未满足的需求和潜在的HealthTech解决方案。归纳定性内容分析生成了候选解决方案领域的长列表，这些解决方案领域被映射到呼吸技术景观审查中，以产生当前技术能力的证据摘要。这些成果为多利益攸关方共识研讨会提供了信息，以确定CRD的前20个卫生技术优先解决方案领域。结果通过调查和有针对性的讨论，共有314名患者、护理人员和卫生保健专业人员做出了贡献。利益相关者确定了741个挑战和555个潜在的HealthTech解决方案，这些解决方案被综合为16个优先领域的73个候选解决方案领域。技术景观回顾发现，52/73（71.2%）的解决方案领域仍未得到满足，21/73（28.8%）的解决方案领域已被现有的HealthTech部分满足；没有一个被认为是完全满足的。一个多利益攸关方共识研讨会确定了CRD的20个医疗技术优先解决方案领域。这种利益相关者知情的卫生技术优先级将未满足的需求与当前的技术能力结合起来，为CRD的政策和资助决策提供信息。HealthTech优先排序的方法可以应用于呼吸系统护理之外。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Thorax 医学-呼吸系统

CiteScore

16.10

自引率

2.00%

发文量

197

审稿时长

1 months

期刊介绍： Thorax stands as one of the premier respiratory medicine journals globally, featuring clinical and experimental research articles spanning respiratory medicine, pediatrics, immunology, pharmacology, pathology, and surgery. The journal's mission is to publish noteworthy advancements in scientific understanding that are poised to influence clinical practice significantly. This encompasses articles delving into basic and translational mechanisms applicable to clinical material, covering areas such as cell and molecular biology, genetics, epidemiology, and immunology.